
    
      To list in cases with unresectable, metastatic or locally advanced biliary tract or ampullary
      adenocarcinoma that have not been treated before,confirm the efficacy and safety of combined
      S-1/L-OHP regimen for the biliary tract or ampullary carcinoma, providing evidence-based
      proof for the future treatment.
    
  